This is a service of

a digital news provider

Amyotrophic Lateral Sclerosis Drugs News

> Amyotrophic Lateral Sclerosis Drugs

Amyotrophic Lateral Sclerosis Drugs News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.

FORMATS: RSS | EMAIL

Latest Amyotrophic Lateral Sclerosis Drugs News

Sort by: relevance (24 hours) relevance date

ALS or basic? Cost is issue 6 Dec 2009 06:31 GMT
... has enough volunteers to staff three of nine ambulances with responders trained ... That medic can be responsible for answering ALS calls in a very large area, the ... allows a rescue worker to administer life-saving drugs and procedures to patients. An ALS-certified medic ...
Stem cell research shows promise in state 6 Dec 2009 03:34 GMT
... for other costly, debilitating diseases including Parkinson's, amyotrophic lateral sclerosis, spinal cord injury, burns, heart disease, diabetes ... of yourself. (Humans, along with most other mammals, have about 25,000 genes. In humans, they're ... "Some may be used to develop patient-specific drugs to treat heart problems, for example." This ...
CytRx Announces That FDA Lifts Clinical Hold of Arimoclomol in ALS 2 Dec 2009 13:51 GMT
... the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the U.S. Food and Drug Administration's (FDA) acceptance of a ...
Chaperone Gets a Lift: CytRx's ALS Drug Back to Clinic at Last 3 Dec 2009 02:31 GMT
... Chaperone Gets a Lift: CytRx's ALS Drug Back to Clinic at Last Investors of ... hold on molecular chaperone amplifier arimoclomol in amyotrophic lateral sclerosis, an event that positions the firm to ... 30 ALS patients - over a three-month treatment period. Fifteen patients will receive a combination ...
CytRx Announces That FDA Lifts Clinical Hold of Arimoclomol in ALS --Company Permitted to Resume Clinical Testing as FDA Accepts Revised Protocol for Ascending Dose Trial-- 2 Dec 2009 13:50 GMT
... FDA Lifts Clinical Hold of Arimoclomol in ALS --Company Permitted to Resume Clinical Testing as FDA ... chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the ...
FDA Lifts Hold On ALS Treatment 3 Dec 2009 04:31 GMT
... suspension on development of arimoclomol as a treatment for Lou Gehrig's disease. The news follows ... brain and spinal cord. Also known as amyotrophic lateral sclerosis or ALS, it currently has no cure or treatment that ...
CytRx says FDA lifts 2 - year suspension of Lou Gehrig's disease treatment development 2 Dec 2009 14:58 GMT
... suspension on development of arimoclomol as a treatment for Lou Gehrig's disease. The news follows ... brain and spinal cord. Also known as amyotrophic lateral sclerosis or ALS, it currently has no cure or treatment. CytRx ...
CytRx says FDA lifts 2 - year suspension on development of treatment for Lou Gehrig's disease 2 Dec 2009 15:50 GMT
... suspension on development of arimoclomol as a treatment for Lou Gehrig's disease. The news follows ... brain and spinal cord. Also known as amyotrophic lateral sclerosis or ALS, it currently has no cure or treatment that ...
CytRx Corporation (NASDAQ:CYTR) Shaping Up To Be A Winner (NAS:CYTR) 2 Dec 2009 17:06 GMT
... into quite a rebound story. This morning, officials at the company have announced that they ... candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the ... acquiring "a company or two" with oncology drugs in Phase II and III of development. ...
CytRx Corporation (NASDAQ:CYTR) Shaping Up To Be A Winner 2 Dec 2009 16:16 GMT
... into quite a rebound story. This morning, officials at the company have announced that they are ... chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the ...
Research Explains Workings of Anti-Cancer Drug 1 Dec 2009 04:31 GMT
... the further development of more efficient TM-based drugs. The study will be published in "Essential metals are at the center of many emerging ... pathogenesis of neurodegenerative diseases such as familial amyotrophic lateral sclerosis (ALS), Parkinson's disease, multiple sclerosis and Alzheimer's ...
FDA approves revised clinical trial protocol for CytRx' arimoclomol 2 Dec 2009 15:18 GMT
... the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), following the U.S. Food and Drug Administration’s (FDA) acceptance of a ...
CytRx Corporation (NASDAQ: CYTR) Looking More Like a Solid Rebound Play 2 Dec 2009 16:31 GMT
... candidate Arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). Just yesterday, the ... acquiring "a company or two" with oncology drugs in Phase II and III of development. ...
News and FDA Updates for Abiomed (NASDAQ:ABMD), CytRx (NASDAQ:CYTR), Bristol-Myers Squibb (NYSE:BMY) 4 Dec 2009 06:19 GMT
... updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions. A complete ... during high-risk percutaneous coronary intervention (PCI) and treatment of acute myocardial infarction (AMI). On 12/02/09, ... candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig´s disease), following the ...
CytRx: FDA lifts 2-year hold on arimoclomol tests 2 Dec 2009 15:40 GMT
... suspension on development of arimoclomol as a treatment for Lou Gehrig's disease. The news follows ... brain and spinal cord. Also known as amyotrophic lateral sclerosis or ALS, it currently has no cure or treatment that ...

1 - 15 / 183 NEXT >>>

NOT SATISFIED WITH THIS AMYOTROPHIC LATERAL SCLEROSIS DRUGS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.

These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>

Pictures of the Day

ap.org:
'Doughnut Hole' Unites Seniors Wary of Health Bill
Medicare & Drugs News

cnn.com:
College Students Encouraged to Get H1N1 Vaccine
Swine Flu Vaccine News

bbc.co.uk:
'Double Trouble' Antibiotic Hope
Antibiotics News

healthday.com:
Diabetes Drugs Go Head-to-Head in Study
Diabetes Drugs News

send press release
PRESSWIRE

Press Release Distribution Service

Blue Spoon Consulting Publishes Generic Design for Marketing Ecosystems [04 Dec 2009]

Follow the Latest Swine Flu Developments with H1N1 News Today [23 Nov 2009]

Mesothelioma News Today Joins the EIN News Network [18 Nov 2009]

Building brands through custom label printing - Print Pelican [11 Nov 2009]

UnitedHealth Supplying Anti-Healthcare Reform Data to Republican Leadership Through Subsidiary, Lewin Group. U.S. Politics Today Offers Complete Coverage [05 Oct 2009]

see all pharmaceuticals press releases »see all press releases »

list your company
DIRECTORY

Accounting Services

Global Technology Forum

PLACE YOUR COMPANY HERE

S E A Consultants Inc.

CNC Global Limited

Toyota Motor Sales USA, Inc.

Huron Consulting Services

British Airways

add listing
EVENTS

LNG 2010

Mining Indaba 2010

NATO - The Road Ahead

11th Southern Africa Energy Week

Oil & Gas Satellite Communications

Unconventional Gas 2010

16th Latin Oil Week 2010

PLACE EVENT LISTING HERE!

FORMATS: RSS

EIN News Columnists

The Success of Obama's Strategy Depends on A Very Shaky Pakistan (Joe Rothstein's Commentary) [05 Dec 2009 - 02:57]
Britain's Officials Tell The Truth About the White House Lies That Led to Iraq (Joe Rothstein's Commentary) [30 Nov 2009 - 20:38]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Pharmaceutical Companies News

Merrion starts phase 1 trial with Novo Nordisk [07 Dec 2009 - 08:38]
Chief Executives' Club: Pfizer CEO Jeffrey Kindler [07 Dec 2009 - 06:14]
Amgen announces results from three studies on the safety and efficacy of Nplate [07 Dec 2009 - 06:13]
Monoclonal Antibodies: Recent findings from Genentech, Inc. highlight research in monoclonal antibodies [07 Dec 2009 - 05:29]
HIV/AIDS: Research data from Bristol-Myers Squibb Company update understanding of HIV/AIDS [07 Dec 2009 - 05:29]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

FDA News

FDA approves new technology tool for breast cancer screening [07 Dec 2009 - 06:31]
FDA Warns of Problems with STERIS 1 Sterilizor [06 Dec 2009 - 19:29]
New FDA Approved Breast Cancer Screening Tool (PRN) [06 Dec 2009 - 18:30]
New FDA Approved Breast Cancer Screening Tool [06 Dec 2009 - 18:29]
FDA issues warning against sterilization device [06 Dec 2009 - 13:28]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Clinical Trials News

Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology Annual Meeting and Exposition [07 Dec 2009 - 09:16]
Positive clinical data from Phase II study of elacytarabine in patients with AML reported [07 Dec 2009 - 09:16]
Updated results from pivotal phase III EXTEND clinical trial of pixantrone announced at ASH annual meeting [07 Dec 2009 - 09:16]
Success of Phase I/II clinical trial of Multimeric-001 Universal Flu Vaccine announced [07 Dec 2009 - 09:16]
Merrion starts phase 1 trial with Novo Nordisk [07 Dec 2009 - 08:38]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Drug News

Ask doctor about halt to Fosamax [06 Dec 2009 - 10:29]
Sun Pharmaceutical gets nod for Oxaliplatin Injection [05 Dec 2009 - 21:29]
Tiger Woods Enjoyed 'Ambien Sex' With Rachel Uchitel [05 Dec 2009 - 21:29]
Simvastatin Crosses Blood-brain Barrier, Prev Dimentia [05 Dec 2009 - 15:27]
Seroquel Wins Approval for Adult, Pediatric Indications [05 Dec 2009 - 10:31]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Generic Drug News

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin [07 Dec 2009 - 09:35]
New drug set to replace warfarin [07 Dec 2009 - 02:30]
Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes [07 Dec 2009 - 02:30]
ADDING and REPLACING Milestone Results in RE-COVER'� Study ' Novel Oral Direct Thrombin Inhibitor Dabigatran Etexilate ' as Effective as Well Controlled Warfarin with Less Bleeding in Treatment of Acute Venous [06 Dec 2009 - 16:28]
ADDING and REPLACING Milestone Results in RE-COVER Study Novel Oral Direct Thrombin Inhibitor Dabigatran Etexilate as Effective as Well Controlled Warfarin with Less Bleeding in Treatment of Acute Venous Thromboembolism [06 Dec 2009 - 16:10]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Heart Drug News

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin [07 Dec 2009 - 09:35]
New drug set to replace warfarin [07 Dec 2009 - 02:30]
Turkey invites anti-torture group to visit �calan's cell [07 Dec 2009 - 02:12]
ADDING and REPLACING Milestone Results in RE-COVER'� Study ' Novel Oral Direct Thrombin Inhibitor Dabigatran Etexilate ' as Effective as Well Controlled Warfarin with Less Bleeding in Treatment of Acute Venous [06 Dec 2009 - 16:28]
ADDING and REPLACING Milestone Results in RE-COVER Study Novel Oral Direct Thrombin Inhibitor Dabigatran Etexilate as Effective as Well Controlled Warfarin with Less Bleeding in Treatment of Acute Venous Thromboembolism [06 Dec 2009 - 16:10]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Painkiller News

Anticoagulants aspirin and heparin to prevent clots in placental blood vessels ineffective, reveals research [07 Dec 2009 - 09:35]
Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes [07 Dec 2009 - 02:30]
Merck Knew Vioxx Risks YEARS Before Pulling from the Market [06 Dec 2009 - 23:30]
Merck Argues VIOXX® Case before U.S. Supreme Court [06 Dec 2009 - 15:28]
Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effec [06 Dec 2009 - 15:27]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Cancer Drug News

Tiger in tabloid bunker [07 Dec 2009 - 08:12]
Tiger Woods in tabloid bunker [07 Dec 2009 - 06:31]
Tiger Woods case is hardly the same as steroids story [07 Dec 2009 - 06:11]
Tiger Woods' latest: Local woman details steamy affair in tabloid [07 Dec 2009 - 05:28]
Russian tabloid hacked, loses entire archives [07 Dec 2009 - 00:29]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Cholesterol Drug News

Simvastatin Crosses Blood-brain Barrier, Prev Dimentia [05 Dec 2009 - 15:27]
TriCor and Adderall lawsuits settled [03 Dec 2009 - 12:03]
Abbott Agrees to Allow Teva to Market Generic TriCor [02 Dec 2009 - 09:37]
Abbott gives Teva TriCor rights as early as 2011 [01 Dec 2009 - 15:45]
Abbott settles patent suit over TriCor [01 Dec 2009 - 08:15]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Diabetes Drug News

Diabetic women resist insulin [07 Dec 2009 - 03:12]
UK Diabetic Cohort Analysis Confirms Sulfonylurea Risks, Adds to Glitazone Debate [06 Dec 2009 - 05:11]
Cardiovascular risk in youth with type 1 diabetes linked primarily to insulin resistance [05 Dec 2009 - 17:30]
Herbal Insulin Resistance Treatment Options Reviewed [04 Dec 2009 - 22:11]
UK diabetic cohort analysis confirms sulfonylurea risks, adds to glitazone debate [04 Dec 2009 - 19:48]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

Antibiotics News

Antibiotics: New antibiotics study results from K. Miliani et al described [07 Dec 2009 - 05:29]
ISDA says there's a 75% decrease in production of antibiotics [07 Dec 2009 - 05:29]
Where to Find Free Antibiotics [06 Dec 2009 - 13:08]
Production of antibiotics running low in the U.S. [05 Dec 2009 - 04:50]
Need For A Global Strategy To Develop New Antibiotics [04 Dec 2009 - 11:41]

MORE ARTICLES >>>

FORMATS: RSS | EMAIL

HIV Drug News

Better than interferon alone for renal cell carcinoma? [05 Dec 2009 - 03:14]
Influence of immunotherapy with interferon-alpha on regulatory T cells in renal cell carcinoma patients [04 Dec 2009 - 07:13]
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib [04 Dec 2009 - 07:13]
More trouble with Gardasil [04 Dec 2009 - 05:17]
Abacavir-Lamivudine versus Tenofovir-Emtricitabine for Initial HIV-1 Therapy [04 Dec 2009 - 05:16]

MORE ARTICLES >>>

Pharmaceutical Industry Today

Drugs & Pharmaceuticals News Sections
Miscellaneous News Sections
Pharmaceuticals News by Region
Pharmaceuticals News by Country
Pharmaceuticals News by U.S. State

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

ALL NEWS PUBLICATIONS

You are currently reading Pharmaceutical Industry Today, an EIN News publication.

EIN News provides breaking news coverage on the following topics:

Regional / Politics
Barack Obama
Central Europe
China
EU Politics
Hillary Clinton
International Development
Military
Russia
US Politics
World News
Automotive
Automotive
Electric Cars
Hybrid Cars
Trucks Energy
Biofuels
Electric Power
Energy
Ethanol
Geothermal Power
Nuclear Power
Oil & Gas
Power Plants
Renewable Energy
Solar Energy
Wind Energy
Health / Pharmaceuticals
Brain Cancer
Breast Cancer
H1N1
Health
Lung Cancer
Mesothelioma
Pharmaceuticals
Prostate Cancer Business / Finance
Banking
Conferences
Employment
FOREX Trading
Finance
Gold
International Trade
Investing
Marketing
Real Estate
Science / Technology
Biotechnology
Environment
Global Warming
IT
Nanotechnology
Semiconductors
Software
Technology Culture / Society / Lifestyle
Books
Consumer
Human Rights
Media
Movies
Music
Religion
Travel
Company Daily Reports
Airbus
BP Energy
Boeing
Coca-Cola
ConocoPhillips
Exxon Mobil
Gazprom
Pepsi-Cola
Shell Energy
Starbucks Industry
Agriculture
Airlines
Chemicals
Cosmetics
Mining
Mobile Phone
Patents & Trademarks
Shipping & Logistics
Textiles
Tobacco
Waste Management
Food / Beverages
Beverages
Fast Food
Food Industry
Food Safety
Organic Food
Seafood

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.